NAD+ injection vs oral drops
NAD+ injection vs oral drops: different routes, no proven outcomes winner.
NAD+ injections and oral liquid drops deliver the same named coenzyme by different routes, but current human evidence does not establish that either route produces better energy, cognition, recovery or longevity outcomes. An injection bypasses the digestive tract. Luvo's liquid product is held under the tongue and then swallowed. Neither oral NR/NMN precursor trials nor a trial of proprietary LathMized NAD+ powder establishes benefits for these drops. Luvo's injection and drops pages each advertise $99.50 for the first four weeks, then $199 every four weeks from the second delivery. A comparable dose and complete treatment bill are not established. Choose by the exact product, route, prescription, full payment terms and a clinician's assessment.
This comparison exists because readers search for the distinction. Search demand does not establish that either product works, belongs in the same provider table or should be prescribed. We have audited providers only for the side explicitly linked below.
| Question | NAD+ injection | NAD+ oral liquid drops |
|---|---|---|
| How is it taken? | Injected under clinical guidance; the exact schedule depends on the prescription. | Luvo describes a sublingual liquid, held under the tongue and then swallowed. |
| Does one route have better human outcomes evidence? | No comparative outcomes winner was established by the sources reviewed here. | No comparative outcomes winner was established by the sources reviewed here. |
| Is this the same as NR or NMN? | No. Those are NAD+ precursors, not the same administered ingredient and route. | No. A direct NAD+ liquid is not automatically evidence-equivalent to an NR or NMN supplement. |
| What price does Luvo publish? | $99.50 for the first four weeks, then $199 every four weeks. | $99.50 for the first four weeks, then $199 every four weeks. |
What is the difference between NAD+ injections and oral drops?
The immediate difference is delivery. An injection places the product outside the digestive tract. Luvo's liquid-drop directions use a sublingual step, followed by swallowing. That route distinction does not supply a head-to-head clinical result.
Formulation, concentration, prescribed amount, frequency, storage and pharmacy still need to be confirmed for the actual order. A shared ingredient name does not make two products dose-equivalent.
Do NAD+ oral drops work as well as injections?
The source set reviewed for this page does not establish equal or superior clinical outcomes for either route. Current human NAD+ supplementation literature is dominated by oral precursor studies, particularly NR and NMN, while direct injected, infused or oral NAD+ outcomes evidence remains limited.
Claims about faster absorption or stronger effects should not be converted into a promise about energy, cognition, recovery or lifespan without relevant comparative human outcomes.
What does the LathMized NAD+ oral-powder trial show?
The 2026 RENEWAL-NAD+ trial tested proprietary LathMized NAD+ (LNAD+) powder using an oral swish-and-swallow protocol for five days in healthy adults aged 45 to 75. The primary analysis included 50 people. At Day 6, the study reported an estimated 53% increase versus placebo in whole-blood intracellular NAD. This assay measures total NAD, including NAD+ and NADH, and largely reflects red blood cells. Plasma NAD did not significantly change.
The clinical laboratory, vital-sign and wellbeing findings did not survive the study's global correction for multiple comparisons. No wearable endpoint remained significant after its correction either. A blood biomarker change does not establish better energy, cognition, recovery or lifespan. The trial compared this powder with placebo, not Luvo drops, nasal sprays or injections.
BioNADRx/Bryleos sponsored the study, and authors disclosed financial interests. Registration was retrospective, and one placebo participant was excluded from the primary analysis after unblinding. The authors report materially unchanged sensitivity results. The short study cannot establish long-term benefit or safety.
Are NAD+ drops the same as oral NR or NMN supplements?
No. NR and NMN are precursors the body can use in NAD+ biosynthesis. Luvo's drops list nicotinamide adenine dinucleotide itself as the active ingredient. Ingredient identity and route both matter when reading a study.
A trial showing that an oral precursor changes a biomarker cannot establish the effectiveness of direct NAD+ drops or an injection subscription.
How much do Luvo NAD+ injections and drops cost?
The injection and liquid-drops product pages each advertise $99.50 for the first four weeks, then $199 from the second delivery on a four-week delivery schedule. These are separately published product offers, not a promise of dose equivalence or equal clinical results.
The public pages do not establish a comparable dose or supplied quantity for each route. Confirm the product, quantity, complete checkout total, renewal processing date and assigned pharmacy before treating the prices as equivalent.
Where can I compare NAD+ injection providers?
Longevity Ranked separately audits online injection plans by first payment, renewal, pharmacy disclosure, cancellation terms and unresolved fees. Oral-drop offers do not enter that injection table as equivalent rows.
Luvo is the only provider in this page's current source set with an approved product-specific link for both an audited injection plan and NAD+ liquid drops. Partner status does not determine the evidence conclusion or table order.
Approved partner · source-audited provider
Embody
Embody NAD+: $49.00 first month, then $99.00/month.
The public offer includes telemedicine, prescription if approved and shipping. It advertises 500 to 1,000 mg options without mapping the introductory or renewal price to one supplied quantity. The first-month promotion has no published end date; confirm availability and the complete selected order.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers and open the exact product page. This relationship does not change comparison order or review findings. Official price source. Checked October 13, 2026.
Approved partner · source-audited provider
Luvo Health
Luvo Health: NAD+ injections and liquid drops.
Luvo's NAD+ injection and liquid-drops pages each advertise $99.50 for the first four weeks, then $199 every four weeks from the second delivery. The routes are not evidence-equivalent; confirm quantity, fees and the next processing date.
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers. Broad Luvo placements open its longevity program; treatment pages and product buttons use the exact approved destination. This relationship does not change comparison order or the review findings. Official price source. Checked October 8, 2026.
Approved partner · source-audited provider
PeterMD
PeterMD NAD+: injection and capsule routes.
PeterMD lists $369 for an 8 to 10-week injection supply and capsule terms from $125.65 for 30 days. Route, formulation and quantities differ, so these are separate decisions.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers. Broad placements use the longevity catalog; product buttons use the exact approved destination. This relationship does not change comparison order or review findings. Refund and auto-bill policy. Checked September 22, 2026.
Which sources support this comparison?
These sources were checked October 8, 2026 (LNAD+ study and Luvo prices); September 21, 2026 (background clinical sources). They define the product, population and regulatory boundaries used above; they do not determine individual suitability.
- Luvo Health: NAD+ injection product
- Luvo Health: NAD+ oral liquid drops
- Gallagher and Emmanuel: systematic review of NAD+ supplementation (2026)
- Radenkovic et al.: clinical evidence for targeting NAD+ therapeutically (2020)
- Luvo Health: published term pricing
- Kornilov et al.: randomized oral LathMized NAD+ trial (2026)
Popular X vs Y questions
Continue with another evidence comparison.
We publish a comparison when people are searching for the distinction, even when only one side has audited providers. Inclusion is not an endorsement.
NMN vs NAD+
NMN is a precursor; NAD+ is a coenzyme. Compare supplements and injections, human trial findings, safety limits and what to check before buying.
These are products marketed in the longevity category, not established lifespan-extension treatments. Compounded drugs are not FDA-approved. This publication compares public information; a clinician must assess individual suitability. How we compare.